Stockreport

How Innate Pharma (ENXTPA:IPH) Story Is Shifting Around 2026 Catalysts And €8 Target [Yahoo! Finance]

Innate Pharma S.A. - American Depositary Shares  (IPHA) 
PDF Analysts are now discussing an updated €8 price target for Innate Pharma, while the fair value estimate sits at €6.10 with no change to the underlying model. This shift [Read more]